Genetic diversity of mitomycin C-hypersensitive Chinese hamster cell mutants: a new complementation group with chromosomal instability

scientific article published on 01 September 1993

Genetic diversity of mitomycin C-hypersensitive Chinese hamster cell mutants: a new complementation group with chromosomal instability is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF01233248
P698PubMed publication ID8291021

P2093author name stringF Arwert
M A Rooimans
M Z Zdzienicka
P Telleman
I Neuteboom
W J Overkamp
P433issue5
P921main subjectgenetic diversityQ585259
P304page(s)431-437
P577publication date1993-09-01
P1433published inSomatic Cell and Molecular GeneticsQ7559232
P1476titleGenetic diversity of mitomycin C-hypersensitive Chinese hamster cell mutants: a new complementation group with chromosomal instability
P478volume19

Reverse relations

cites work (P2860)
Q33575946A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors
Q28293238Assignment of the XRCC2 human DNA repair gene to chromosome 7q36 by complementation analysis
Q34440261Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions
Q24317605Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene
Q53963846Deficiency in BRCA2 leads to increase in non-conservative homologous recombination.
Q40895867Involvement of apoptosis in mitomycin C hypersensitivity of Chinese hamster cell mutants
Q40997032Lack of correlation between repair of DNA interstrand cross-links and hypersensitivity of hamster cells towards mitomycin C and cisplatin
Q33601058Mammalian X-ray-sensitive mutants which are defective in non-homologous (illegitimate) DNA double-strand break repair
Q41027960Mechanisms determining sensitivity to cisplatin in three mutant Chinese hamster ovary cell lines
Q42733515Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance
Q34698753The inhibition and treatment of breast cancer with poly (ADP-ribose) polymerase (PARP-1) inhibitors

Search more.